Joel Greenblatt Regeneron Pharmaceuticals, Inc. Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 5,627 shares of REGN stock, worth $4.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,627

Previous 5,700 1.28%

Holding current value

$4.03 Million

Previous $5.99 Million 1.25%

% of portfolio

0.06%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $74,758 - $87,728	-73 Reduced 1.28%	5,627 $5.92 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $2.07 Million - $2.51 Million	2,345 Added 69.9%	5,700 $5.99 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $185,954 - $204,630	206 Added 6.54%	3,355 $3.23 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $75,967 - $86,406	-98 Reduced 3.02%	3,149 $2.77 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $4.57 Million - $5.58 Million	-6,606 Reduced 67.05%	3,247 $2.67 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $4.13 Million - $4.9 Million	5,897 Added 149.06%	9,853 $7.08 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $155,151 - $188,549	-228 Reduced 5.45%	3,956 $3.25 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $978,363 - $1.06 Million	-1,386 Reduced 24.88%	4,184 $3.02 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $4.97 Million - $6.27 Million	-8,660 Reduced 60.86%	5,570 $3.84 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $477,064 - $642,790	-870 Reduced 5.76%	14,230 $8.41 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $5.1 Million - $5.98 Million	-8,564 Reduced 36.19%	15,100 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $9.92 Million - $12.3 Million	18,261 Added 337.98%	23,664 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.07 Million - $1.27 Million	1,871 Added 52.97%	5,403 $3.27 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $126,237 - $149,130	267 Added 8.18%	3,532 $1.97 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $347,555 - $426,499	-778 Reduced 19.24%	3,265 $1.55 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $4.2 Million - $5.34 Million	-8,786 Reduced 68.49%	4,043 $1.95 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $4.67 Million - $5.65 Million	8,581 Added 202.0%	12,829 $7.18 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $329,537 - $430,138	-668 Reduced 13.59%	4,248 $2.65 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $1.07 Million - $1.57 Million	3,184 Added 183.83%	4,916 $2.4 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.01 Million - $1.39 Million	-3,681 Reduced 68.0%	1,732 $650,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $7.8 Million - $9.08 Million	-28,527 Reduced 84.05%	5,413 $1.5 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $5.66 Million - $7.84 Million	18,900 Added 125.66%	33,940 $10.6 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.47 Million - $1.74 Million	3,954 Added 35.67%	15,040 $6.18 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $305,596 - $366,766	-910 Reduced 7.59%	11,086 $4.14 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $3.52 Million - $4.1 Million	-10,026 Reduced 45.53%	11,996 $4.85 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $5.11 Million - $6.2 Million	17,972 Added 443.75%	22,022 $7.6 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $34,424 - $42,922	-109 Reduced 2.62%	4,050 $1.4 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $10.8 Million - $14.1 Million	-30,016 Reduced 87.83%	4,159 $1.56 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $14.7 Million - $17.2 Million	34,175	34,175 $15.3 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account